IGXT
$0.65
Intelgenx Technologs
($.04)
(5.11%)
IGXT
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  ($0.03)
Revenue:  $0.20 Mil
Thursday
Nov 7
7:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when IGXT reports earnings?
Beat
Meet
Miss

Where is IGXT's stock price going from here?
Up
Flat
Down
Stock chart of IGXT
Analysts
Summary of analysts' recommendations for IGXT
Score
Grade
Pivots
Resistance
$0.73
$0.71
$0.68

$0.66

Support
$0.63
$0.61
$0.58
Tweet
Growth
Description
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The Company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. The Company's research and development pipeline includes products for the treatment of osteoarthritis pain management, hypertension and smoking cessation.
Peers
Regeneron PharmaceuticalsCelgeneInterCeptVertex PharmaceuticalsBioMarin PharmaceuticalEndo International plcJohnson & JohnsonMylanZoetisPerrigo